.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2013 for an enormous $4...
.On the heels of a period 3 win that failed to blow away real estate investors, Ironwood Pharmaceuti...
.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is enjoying after signing a ...
.Welcome to recently's Chutes & Ladders, our summary of considerable management hirings, shooting...
.Commemorating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer call...
.AbbVie has returned to the resource of its antipsychotic powerhouse Vraylar seeking another smash h...
.GenSight Biologics is full weeks out of losing loan. Once more. The biotech just possesses enough m...
.Monopar Therapies is actually recovering a medication from the scrap heap of AstraZeneca's rare ail...
.With brand-new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of experts e...
.After forming a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is actually back f...